Skip to main content
logo
3D Medicines Inc. (HKG:1244)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.470
+0.210 (9.29%)
Sep 18, 2026, 4:08 PM HKT

3D Medicines Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6071,3087551,7329,491-
Market Cap Growth
-68.41%73.29%-56.44%-81.75%--
Enterprise Value
287904-121,23912,525-
Last Close Price
2.475.333.087.6442.50-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.473.301.592.4814.80-
PB Ratio
1.122.161.011.819.38-
P/TBV Ratio
1.001.970.901.688.91-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.692.28-1.7719.53-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.360.280.340.320.20-1.40
Net Debt / Equity Ratio
-0.47-0.52-0.86-0.82-0.86-1.04
Net Debt / EBITDA Ratio
1.261.432.721.462.03-4.58
Net Debt / FCF Ratio
-1.792.364.742.30-5.62
Asset Turnover
0.340.330.340.460.470.08
Inventory Turnover
21.0115.1017.0538.20169.03-
Quick Ratio
1.011.391.982.162.920.28
Current Ratio
1.211.452.032.193.040.28
Return on Equity (ROE)
-32.79%-29.62%-25.33%-63.70%--
Return on Assets (ROA)
-11.04%-11.98%-10.90%-22.51%-20.18%-41.80%
Return on Capital Employed (ROCE)
-37.90%-37.40%-31.70%-53.60%-40.40%23.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.96%-15.10%-25.76%-33.37%-12.20%-
FCF Yield
--13.55%-36.09%-9.59%-3.96%-
Buyback Yield / Dilution
-0.38%-0.22%-7.22%-402.26%-16.48%14.36%